Suicides By Americans Aged 10 To 24 Continuing To Climb, Data Indicate

HealthDay (9/5, Mundell) reports, “Suicides by Americans aged 10 to 24 are continuing to climb and guns are increasingly the method of choice in these tragedies,” according to a study that examined “U.S. federal data on all suicide deaths among people ages 10 through 24 from 2013 to the end of 2020.” The study encompassed “a total of more than 49,500 suicides…recorded during that time for this age group.” The findings were published online in a research letter in JAMA Pediatrics.

Related Links:

— “Gun Suicides Keep Rising Among U.S. Youth,”Ernie Mundell, HealthDay, September 5, 2023

Study Finds Online Pharmacy Programs Could Save Patients Money On Prescription Drug Costs Compared To Traditional Insurance Plans

NBC News (9/5, Lovelace) reports, “Patients could save millions of dollars by buying prescription drugs through online pharmacy discount programs instead of through traditional insurance plans, a study published Monday in the journal Annals of Internal Medicine finds.” Researchers “looked at 20 commonly prescribed generic drugs, including statins, heart failure medications and antidepressants,” and “found that at least 1 out of 5 prescriptions were cheaper through the Amazon or GoodRx discount card programs compared to what patients actually paid out of pocket for the drugs.”

Related Links:

— “Online pharmacy programs can save patients millions in prescription drug costs, study finds,”Berkeley Lovelace Jr., NBC News, September 5, 2023

Medication Shortages For ADHD Affecting High School And College Students At Start Of New School Year

CNN (9/4, Bonifield) reported on how medication shortages for the treatment of attention-deficit/hyperactivity disorder (ADHD) are affecting high school and college students as this year’s school season begins. Currently, 11 pharmaceutical makers “are listed as making Adderall” (amphetamine/dextroamphetamine salts) “or its generic versions on the FDA’s shortages website, and while some say the medicine is available, others don’t foresee an end to the shortage until December.” Consequently, “‘a lot of the young people that I’ve been treating have had difficulties getting their medications month to month,’ said…Warren Ng,” MD, “a professor of psychiatry at Columbia University Medical Center who also serves as president for the American Academy of Child and Adolescent Psychiatry.” If they cannot get medication, many young people with ADHD “fail classes, are held back from going to the next grade, get sent to the principal’s office and have trouble doing homework, Ng said.”

Related Links:

— “ADHD drug shortage stresses families during back-to-school season,”Meg Tirrell and Amanda Sealy, CNN, September 4, 2023

Percentage Of Overdose Deaths In The US Involving Counterfeit Pills More Than Doubled Between Late 2019 And Late 2021, Research Suggests

Psychiatric News (9/1) reported, “The percentage of overdose deaths involving counterfeit” medications “in the United States more than doubled between late 2019 and late 2021, according to findings (8/31)” published online Sept. 1 in the CDC’s Morbidity and Mortality Weekly Report. The study team came to this conclusion after calculating “quarterly percentages of overdose deaths with evidence of counterfeit pill use from July 2019 to December 2021 based on information provided by officials from 29 states and the District of Columbia,” then “also examined information about the demographics of the people who died by overdose, the circumstances of the death, and the” counterfeit pills involved.

Related Links:

— “Counterfeit Pills Increasingly Involved in U.S. Overdose Deaths, Psychiatric News, September 1, 2023

CDC reports overdose deaths from fake prescription pills have more than doubled in recent years

NBC News (8/31, Edwards) reports, “The number of people who have overdosed and died from fake prescription pills has more than doubled in recent years, the Centers for Disease Control and Prevention reported Thursday.” The report by the CDC, “released to coincide with International Overdose Awareness Day, found that from mid-2019 to the end of 2021, overdose deaths involving counterfeit drugs more than doubled, from 2% to 4.7%.” Among deaths involving fake pills, “illicit fentanyl was detected in 93%,” and “more than half of the deaths – 57.1% – occurred among people younger than 35.”

The Hill (8/31, Sforza) reports, “In total, there were more than 54,000 overdose deaths with evidence of counterfeit pill use.” The report “found that more than half of the deaths with evidence of fake pill use were related to counterfeit oxycodone or with counterfeit alprazolam, which is more commonly sold under the brand name Xanax.”

CNN (8/31, McPhillips) reports, “Methamphetamine was detected in about a quarter of deaths where counterfeit pills were involved, while cocaine and benzodiazepines were present in more than one in eight cases.”

Related Links:

— “Overdose deaths from fake pills are rising, especially among younger adults,” Erika Edwards, NBC News, August 31, 2023

Biden Administration Announces $450M Effort To Fight Opioid Overdoses

Bloomberg (8/31, Beckwith, Subscription Publication) reports, “The Biden administration announced a $450 million effort to fight overdoses caused by fentanyl and other opioids amid a nationwide surge that has become a 2024 campaign issue.” In a briefing Thursday, “White House Domestic Policy Advisor Neera Tanden said…the money would be spent on prevention, harm reduction, treatment and recovery services, as well as cracking down on drug trafficking.”

The Hill (8/31, Gangitano) reports, “The investment on Thursday also includes the Substance Abuse and Mental Health Services Administration awarding more than $57.6 million to connect Americans to substance use treatment and recovery support services.” And the CDC “will award $279 million in Overdose Data to Action grants to states and localities to expand harm reduction strategies.”

Related Links:

— “Biden administration announces $450M in funding to beat overdose epidemic,”Alex Gangitano, Bloomberg, August 31, 2023

Suicide Hotline 988 Funding Depends On States, But Most Do Not Have Permanent Funding Options

CBS News (8/31, Saint Louis) publishes a KFF article that reports, “Since the National Suicide Prevention Lifeline transitioned a year ago to the three-digit crisis phone number 988, there has been a 33% increase in the number of calls, chats, and texts to the hotline.” But “even with that early sign of success, the program’s financial future is shaky.” Although “the federal government has provided about $1 billion…to launch the number,” after that, “it’s up to states to foot the bill for their call centers.”

Related Links:

— “Most states have yet to permanently fund 988 Lifeline despite early successes,”Christina Saint Louis, CBS News, August 31, 2023

Family Members Of Patients With COVID-19 Experience Anxiety, PTSD, Studies Find

Healio (8/30, Hornick) reports, “The impact of COVID-19 extends beyond those who get infected and evokes symptoms of anxiety, depression and PTSD in their families, according to two studies published in Annals of the American Thoracic Society.” In one study, investigators “analyzed 90 families of patients who had COVID-19 between September 2020 and April 2021 to determine the prevalence of anxiety, depression and stress while their relative was in the ICU compared with after their time in the ICU.” In the other study, researchers “assessed 115…family members of patients with COVID-19 in the ICU across five states to understand how PTSD symptoms vary at different times points within 1 year of their relative entering the ICU.”

Related Links:

— “Families of patients with COVID-19 suffer with anxiety, depression, PTSD,”Isabella Hornick, Healio, August 31, 2023

Narcan To Become Available Over The Counter Soon

The New York Times (8/30, Hoffman, Weiland) reports, “Narcan, the first opioid overdose reversal medication approved for over-the-counter purchase, is being shipped to drugstore and grocery chains nationwide, its manufacturer said Wednesday.” Earlier this summer, the FDA “gave over-the-counter approval to RiVive, a naloxone spray expected in early 2024. RiVive, manufactured by Harm Reduction Therapeutics, is intended as a low-cost product largely for outreach groups.” Pharmacies at “Walgreens, CVS, Walmart and Rite Aid said they expected Narcan to be available online and on many store shelves early next week.”

NBC News (8/30, Lovelace) reports the FDA’s approval means the drug “can be sold in even more places, including…airports and even vending machines.” It “could also be available to buy online from some businesses this week.” However, its price tag of $44.99 for two doses “may put it out of reach for some.”

CNN (8/30, Tirrell, Kounang) also reports.

Related Links:

— “Narcan Is Headed to Stores: What You Need to Know,”Jan Hoffman and Noah Weiland, The New York Times , August 30, 2023